Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Gene Therapy
|
July 6, 2019
Genetic therapies, human genetic enhancement, and … eugenics?
Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 22, 2007
A decade of accomplishments: gene therapy and the ASGT
Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 1, 2009
An integrated funding mechanism for clinical trials in human gene therapy
Arthur Nienhuis, Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2007
Tissue-specific aberrations of gene expression in HPRT-deficient mice: functional complexity in a monogenic disease?
Shaochun Song, Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2005
Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein
Ghiabe H Guibinga, Theodore Friedmann
Gene Therapy
|
January 3, 2024
Correction: Cost of gene therapy
Patrick T Harrison, Theodore Friedmann
Neuroreport
|
April 13, 2004
Discrepant effects of culture conditions on survival and function of dopaminergic neurons
Doug W Smith, Theodore Friedmann
Cold Spring Harbor Protocols
|
July 22, 2010
Preparation of pseudotyped lentiviral vectors resistant to inactivation by serum complement
Ghiabe H Guibinga, Theodore Friedmann
BMC Genomics
|
November 19, 2008
Insulin-like growth factor-1 coordinately induces the expression of fatty acid and cholesterol biosynthetic genes in murine C2C12 myoblasts
C Ramana Bhasker, Theodore Friedmann
Advances in Genetics
|
March 1, 2006
Gene doping in sports: the science and ethics of genetically modified athletes
Angela J Schneider, Theodore Friedmann
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Gene Therapy
|
July 6, 2019
Genetic therapies, human genetic enhancement, and … eugenics?
Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 22, 2007
A decade of accomplishments: gene therapy and the ASGT
Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 1, 2009
An integrated funding mechanism for clinical trials in human gene therapy
Arthur Nienhuis, Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2007
Tissue-specific aberrations of gene expression in HPRT-deficient mice: functional complexity in a monogenic disease?
Shaochun Song, Theodore Friedmann
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2005
Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein
Ghiabe H Guibinga, Theodore Friedmann
Gene Therapy
|
January 3, 2024
Correction: Cost of gene therapy
Patrick T Harrison, Theodore Friedmann
Neuroreport
|
April 13, 2004
Discrepant effects of culture conditions on survival and function of dopaminergic neurons
Doug W Smith, Theodore Friedmann
Cold Spring Harbor Protocols
|
July 22, 2010
Preparation of pseudotyped lentiviral vectors resistant to inactivation by serum complement
Ghiabe H Guibinga, Theodore Friedmann
BMC Genomics
|
November 19, 2008
Insulin-like growth factor-1 coordinately induces the expression of fatty acid and cholesterol biosynthetic genes in murine C2C12 myoblasts
C Ramana Bhasker, Theodore Friedmann
Advances in Genetics
|
March 1, 2006
Gene doping in sports: the science and ethics of genetically modified athletes
Angela J Schneider, Theodore Friedmann
Page
of 5